Drug Discovery & Pharmaceuticals

RSS

Genetic differences can influence efficiency of medicines

Medicines do not follow the one size fits all principle, because genetic differences can influence their efficiency.

5 Jan 2018

Study suggests vitamin C enhances tuberculosis drugs effectiveness

A new study conducted by researchers at the Albert Einstein College of Medicine, Bronx, NY, proposed the use of vitamin C together with tuberculosis drugs for rapid eradication of the disease-causing pathogens. The studies were carried out on mice and in tissue cultures and the results have been published in the journal of American Society for Microbiology, Antimicrobial Agents and Chemotherapy.

5 Jan 2018

Why Should We Weigh Every Protein in the Human Body?

Our mission is to advance the measurement of human proteins with greater precision, to bring to the world the benefits of absolute molecular specificity when it comes to interrogating proteins at the molecular level.

From Pittcon 5 Jan 2018

Researchers discover promising drug that shrinks excess fat without lowering food intake

Given the ever-increasing obesity epidemic, researchers from The University of Texas Medical Branch at Galveston have discovered a promising developing drug that has been shown to selectively shrink excess fat by increasing fat cell metabolism.

4 Jan 2018

Newly solved glucagon receptor structure provides most accurate template for drug design

Class B G protein-coupled receptors (GPCRs) exert essential action in hormonal homeostasis and are important therapeutic targets for a variety of diseases including metabolic disorders such as type 2 diabetes.

4 Jan 2018

HKBU experts develop new generation of smart anti-cancer drug molecules

The toxic nature of chemotherapy poses a great challenge to clinical treatment of cancer. A team of scholars from the School of Chinese Medicine of Hong Kong Baptist University devoted their efforts to the development of a new generation of smart anti-cancer drug molecules.

15 Dec 2017

New high precision machine-learning model could help accelerate drug discovery

Drug discovery could be significantly accelerated thanks to a new high precision machine-learning model, developed by an international collaboration of researchers, including the University of Warwick.

14 Dec 2017

Pitting pathogens against each other could prevent drug resistance emerging

Limiting the nutrient resources that pathogens depend on for replication could prevent the emergence of drug resistance, according to research findings. In a study published in Proceedings of the National Academy of Sciences, scientists have taken advantage of the competition that occurs between host pathogens to achieve successful treatment of infection with existing drugs, even when drug-resistant pathogens were present.

12 Dec 2017

Hidden genes hold blueprints for designing new anti-cancer drugs

New research suggests these hidden genes hold the blueprints for designing new, even more effective cancer-targeting compounds.

12 Dec 2017

Breakthrough research could lead to development of yeast-based protein therapies

It took several years, but a research team headed by Professor Jens Nielsen at Chalmers University of Technology has finally succeeded in mapping out the complex metabolism of yeast cells.

11 Dec 2017

OICR announces innovative initiative to drive development of new cancer therapies

The Ontario Institute for Cancer Research today announced the Cancer Therapeutics Innovation Pipeline initiative and the first 10 projects selected in CTIP's inaugural round of funding.

4 Dec 2017

Malvern Panalytical Announce Efforts Towards a Platform For Protein Aggregation Profiling

Malvern Panalytical announces the launch of a collaborative project which aims to support the development of existing and next generation biopharmaceutical products.

From Malvern Panalytical 4 Dec 2017

New discovery could speed up production of cells for studying diseases

Scientists have made a key discovery that could speed up the production of cells in the lab for studying diseases such as multiple sclerosis and Parkinson's disease.

28 Nov 2017

Scientists take major step forward in research efforts to develop TB vaccine

A team of scientists led by the University of Southampton has taken an important step forward in research efforts that could one day lead to an effective vaccine against the world's deadliest infectious disease.

25 Nov 2017

Study records video of colliding organic nanoparticles

A new study conducted at the Northwestern University, published today in the Journal of the American Chemical Society, captured a video of organic nanoparticles colliding and fusing together, a breakthrough in nanotechnology.

20 Nov 2017

UTEP researchers one step closer to developing effective vaccine for cutaneous leishmaniasis

A research team at The University of Texas at El Paso is one step closer to developing an effective human vaccine for cutaneous leishmaniasis, a tropical disease found in Texas and Oklahoma, and affecting some U.S. troops stationed in Afghanistan and Iraq.

15 Nov 2017

University of Michigan and AstraZeneca partner to improve treatment for CKD patients

Patients with Chronic Kidney Disease (CKD) may benefit from a new collaboration between the University of Michigan and AstraZeneca who have partnered to develop a new therapeutic strategy for treatment.

10 Nov 2017

RUDN chemists obtain unusual organic compounds that could be used in pharmaceutics

Researchers from RUDN University conducted an effective three-component reaction, obtaining unusual organic compounds. The latter are structurally similar to a number of biologically active compounds - which makes it possible to use them in pharmaceutics.

9 Nov 2017

New ‘SMART’ system holds potential to accelerate molecular structure identification process

An interdisciplinary team of researchers at the University of California San Diego has developed a method to identify the molecular structures of natural products that is significantly faster and more accurate than existing methods.

8 Nov 2017

Scientists make significant advance towards creating commercially viable superbug-killing antibiotic

Scientists working to develop a 'game-changing' new antibiotic have made a significant advance towards creating commercially viable drug treatments by producing two simplified synthetic versions of the substance which are just as potent at killing superbugs like MRSA as its natural form.

7 Nov 2017